Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study

    Diabetes Care Date published:

  • Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial

    The Lancet Diabetes & Endocrinology Date published:

  • Drawing on Strategic Management Approaches to Inform Nutrition Policy Design: An Applied Policy Analysis for Salt Reduction in Packaged Foods

    International Journal of Health Policy and Management Date published:

  • Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial

    European Heart Journal Date published:

  • Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide

    Journal of the American College of Cardiology Date published:

  • Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes

    Diabetes, Obesity and Metabolism Date published:

  • Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

    Kidney International Date published:

  • Estimated 24-Hour Urinary Sodium Excretion and Incident Cardiovascular Disease and Mortality Among 398 628 Individuals in UK Biobank

    Hypertension Date published:

  • Prospective associations of the original Food Standards Agency nutrient profiling system and three variants with weight gain, overweight and obesity risk: results from the French NutriNet-Santé cohort

    British Journal of Nutrition Date published:

  • diabetologia

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Prospective associations of four nutrient profiles with weigh gain, overweight and obesity risk

    European Journal of Public Health Date published:

  • Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial

    American Heart Journal Date published:

  • Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program

    Diabetes, Obesity and Metabolism Date published:

  • Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial

    The Journal of Clinical Hypertension Date published: